Chemotherapy in Gurgaon and Faridabad
Chemotherapy is an important treatment option for several types of cancer, including leukemia, lymphoma, multiple myeloma and other malignancies. Choosing the right chemotherapy treatment in Gurgaon and Faridabad involves accurate diagnosis, an appropriate treatment protocol and regular monitoring by an experienced specialist team.
BMT Next at Marengo Asia Hospitals, Gurugram and Faridabad, provides specialized Hematology, Hemato-Oncology and Bone Marrow Transplant services. The team evaluates patients with blood cancers and complex hematological disorders and develops individualized treatment plans based on the type of cancer, disease stage, genetic findings and overall health.
Patients looking for a Cancer Specialist in Gurgaon and Faridabad, Hematologist or Blood Cancer Specialist can seek expert evaluation and guidance regarding chemotherapy, targeted treatment, immunotherapy and bone marrow transplantation, wherever clinically appropriate.
Meet Our Cancer Specialists
BMT Next has a specialist team covering adult and pediatric hematology, hemato-oncology and bone marrow transplantation.
Dr. Meet Kumar
Dr. Meet Kumar is a senior clinical hematologist with over 20 years of experience in hematology, hemato-oncology and bone marrow transplantation. His clinical expertise includes the management of complex blood cancers, bone marrow failure syndromes and other hematological disorders.
Patients seeking chemotherapy for blood cancer in Gurgaon and Faridabad can consult the specialist team for evaluation and treatment planning for leukemia, lymphoma, multiple myeloma and other hematological malignancies.
- MBBS
- MD (General Medicine)
- DM in Clinical Hematology – NRS Medical College, Kolkata
- Fellowship in Bone Marrow Transplant – Tata Medical Center, Kolkata
- Advanced Training in CAR-T Cell Therapy – King's College London, UK
Patient Testimonials — Dr. Meet Kumar
Watch clinical recovery journeys and patient outcomes treated under Dr. Meet Kumar.
- Acute Myeloid Leukemia (AML)
- Acute Lymphoblastic Leukemia (ALL)
- Chronic Myeloid Leukemia (CML)
- Chronic Lymphocytic Leukemia (CLL)
- Hodgkin and Non-Hodgkin Lymphoma
- Multiple Myeloma
- Myelodysplastic Syndromes (MDS)
- Aplastic Anemia and other bone marrow disorders
- Autologous, Allogeneic and Haploidentical Bone Marrow Transplant
Dr. Neeraj Teotia
Dr. Neeraj Teotia specializes in pediatric hematology, childhood blood cancers and pediatric bone marrow transplantation. He has received international training in Pediatric Bone Marrow Transplant and Cellular Therapy at the Royal Bristol Hospital for Children, UK.
Families seeking chemotherapy and blood cancer treatment for children in Gurgaon and Faridabad can consult the pediatric hematology team for conditions such as childhood leukemia, lymphoma, aplastic anemia and other complex blood disorders.
- MBBS – JN Medical College, Belgaum
- MD (Pediatrics) – LLRM Medical College, Meerut
- FNB in Pediatric Hematology-Oncology – Rajiv Gandhi Cancer Institute and Research Centre, Delhi
- Fellowship in Pediatric Bone Marrow Transplant & Cellular Therapy – Royal Bristol Hospital for Children, UK
Pediatric Stories & Testimonials — Dr. Neeraj Teotia
Watch pediatric patient recoveries and family experiences under Dr. Neeraj Teotia's care.
- Childhood Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Hodgkin and Non-Hodgkin Lymphoma
- Aplastic Anemia
- Thalassemia and Sickle Cell Disease
- Pediatric Bone Marrow Transplant
- Complex pediatric hematological disorders
Dr. Paras Satadeve
Dr. Paras Satadeve is a clinical hematologist with advanced training in benign hematology, hemato-oncology and bone marrow transplantation. His clinical interests include chronic myeloid leukemia, myelodysplastic syndromes, immune thrombocytopenia and other complex hematological conditions.
- MBBS
- MD (General Medicine) – Gandhi Medical College, Bhopal
- DM (Clinical Hematology) – AIIMS Rishikesh
- European Hematology Association (EHA) Certified Hematologist
- Chronic Myeloid Leukemia (CML)
- Acute Myeloid Leukemia (AML)
- Acute Lymphoblastic Leukemia (ALL)
- Lymphoma and Multiple Myeloma
- Immune Thrombocytopenia (ITP)
- Myelodysplastic Syndromes (MDS)
- Myeloproliferative Neoplasms (MPN)
- Bone Marrow Transplant Evaluation
Dr. Umesh Kumar
Dr. Umesh Kumar is an experienced hemato-oncology and bone marrow transplant specialist with over 10 years of clinical experience in managing blood cancers, complex hematological disorders, and inpatient chemotherapy protocols.
His clinical practice covers the evaluation and management of acute and chronic leukemias, lymphomas, multiple myeloma, aplastic anemia, and post-transplant supportive care at BMT Next, Marengo Asia Hospitals, Gurugram and Faridabad.
- MBBS
- MD (Physician) – International Higher School of Medicine, Bishkek
- Diploma in Hematology – Israel
- Fellowship in Hemato-Oncology, Level 1 – Dr. M.G.R. Medical University, Tamil Nadu
- Acute Myeloid Leukemia (AML) & ALL
- Hodgkin & Non-Hodgkin Lymphoma
- Multiple Myeloma & Plasma Cell Disorders
- Aplastic Anemia & Bone Marrow Failure
- Inpatient Chemotherapy & Supportive Care
- Autologous, Allogeneic & Haploidentical BMT Care
What Is Chemotherapy?
Chemotherapy is a type of cancer treatment that uses medicines to destroy cancer cells or stop them from growing and multiplying. These medicines are known as anticancer drugs and may be administered individually or in combinations, depending on the cancer diagnosis and treatment protocol.
Chemotherapy works by targeting rapidly dividing cells. Since many cancer cells multiply quickly, they are particularly affected by these medicines. However, some healthy cells that also divide rapidly can be affected, which explains common side effects such as hair loss, nausea and reduced blood cell counts.
In patients with blood cancers, chemotherapy may be used to control abnormal blood cells, achieve remission, reduce the risk of relapse or prepare the patient for a bone marrow transplant.
The chemotherapy plan is not the same for every patient. It depends on the type of cancer, disease stage, genetic and molecular findings, previous treatment response and the patient's overall health.
When Is Chemotherapy Recommended?
Chemotherapy may be recommended when cancer cells need to be destroyed, controlled or prevented from spreading. The decision depends on the type of cancer, its stage, genetic characteristics, previous treatment response and the patient's overall health.
A medical oncologist or hemato-oncologist evaluates these factors before selecting an appropriate chemotherapy protocol.
Chemotherapy may be recommended in the following situations:
- To achieve remission: To reduce or eliminate detectable cancer cells, particularly in certain types of leukemia and lymphoma.
- Before surgery or other treatment: Neoadjuvant chemotherapy may help shrink a tumour before surgery in selected cancers.
- After surgery: Adjuvant chemotherapy may help destroy remaining microscopic cancer cells and reduce the risk of recurrence in selected solid tumours.
- To control advanced cancer: Chemotherapy may help slow disease progression and manage symptoms.
- Before Bone Marrow Transplant: High-dose chemotherapy, sometimes combined with radiation, may be used as part of a conditioning regimen before stem cell transplantation.
Not every patient requires chemotherapy. The treatment plan is individualized according to the diagnosis and clinical assessment.
Types of Chemotherapy Treatment
Chemotherapy can be administered using different medicines and approaches. The choice depends on the cancer type, treatment objective and the patient's medical condition.
1. Intravenous Chemotherapy
In intravenous chemotherapy, anticancer medicines are administered directly into a vein through an IV line, cannula or central venous catheter. It is commonly used for several blood cancers, including leukemia, lymphoma and multiple myeloma. The duration of administration depends on the prescribed medicines and treatment protocol.
2. Oral Chemotherapy
Some anticancer medicines are available as tablets or capsules and can be taken by mouth. Examples include selected targeted and chemotherapy medicines used in certain hematological malignancies. Patients must follow the prescribed dose and schedule carefully, as oral cancer medicines also require regular monitoring.
3. Combination Chemotherapy
Combination chemotherapy involves using two or more anticancer medicines together. Different medicines act through different mechanisms to target cancer cells. This approach is commonly used in the treatment of leukemia, lymphoma and multiple myeloma. The specific combination is selected according to the disease and established treatment protocols.
4. High-Dose Chemotherapy
High-dose chemotherapy involves administering intensive anticancer medicines to achieve stronger disease control. In selected patients, it is used as part of the conditioning regimen before an autologous or allogeneic bone marrow transplant. Close monitoring and supportive care are essential because high-dose treatment can significantly suppress normal bone marrow function.
Chemotherapy for Blood Cancer
Chemotherapy remains an important treatment approach for several hematological malignancies. The medicines, combinations and treatment duration vary according to the specific type of blood cancer.
1. Chemotherapy for Leukemia
Leukemia is a cancer involving blood-forming tissues, particularly the bone marrow, leading to abnormal production of blood cells. Chemotherapy is an important treatment component for several types of leukemia.
- Acute Myeloid Leukemia (AML): Treatment may involve intensive induction chemotherapy followed by consolidation treatment. Some patients may require allogeneic bone marrow transplantation.
- Acute Lymphoblastic Leukemia (ALL): Treatment generally involves multiple phases, including induction, consolidation and maintenance, depending on the protocol.
- Chronic Myeloid Leukemia (CML): Targeted medicines called tyrosine kinase inhibitors (TKIs) are the mainstay of treatment for most patients. Chemotherapy or transplantation may be considered in selected situations.
- Chronic Lymphocytic Leukemia (CLL): Treatment may involve targeted therapies, immunotherapy or selected chemotherapy-based combinations, depending on the patient's disease characteristics.
2. Chemotherapy for Lymphoma
Lymphoma is a blood cancer that develops in the lymphatic system. It is broadly classified into Hodgkin lymphoma and Non-Hodgkin lymphoma. Chemotherapy is an important treatment option for many lymphoma patients.
- Hodgkin Lymphoma: Combination chemotherapy is commonly used, sometimes with radiotherapy or other treatments depending on the disease stage.
- Non-Hodgkin Lymphoma: Treatment varies according to the lymphoma subtype, disease stage and clinical condition. Some patients receive combination chemotherapy with immunotherapy.
3. Chemotherapy for Multiple Myeloma
Multiple myeloma is a cancer of plasma cells that develops in the bone marrow. Treatment often involves combinations of medicines, including proteasome inhibitors, immunomodulatory drugs, corticosteroids and monoclonal antibodies. For eligible patients, high-dose chemotherapy followed by autologous stem cell transplantation may be recommended as part of the treatment plan.
How Is Chemotherapy Given?
The chemotherapy process usually follows a planned schedule known as a treatment cycle. Each cycle includes a treatment period followed by a recovery period, allowing the body to recover before the next cycle.
The process generally includes:
- 1. Pre-treatment Assessment: Blood counts, kidney function, liver function and other relevant investigations are reviewed.
- 2. Medicine Administration: Chemotherapy medicines are given intravenously or orally according to the prescribed protocol.
- 3. Monitoring: The medical team monitors the patient's response and checks for possible side effects.
- 4. Recovery Period: A gap between cycles allows normal cells, particularly blood cells, to recover.
- 5. Response Assessment: Blood tests, bone marrow examination, imaging or other disease-specific tests may be performed to assess treatment response.
The number of cycles and duration of chemotherapy vary significantly between different cancers and treatment protocols.
Chemotherapy Side Effects and Their Management
Chemotherapy medicines target cancer cells, but they can also affect some healthy cells that divide rapidly. This may lead to side effects during or after treatment. The type and severity of side effects depend on the medicines used, dosage, treatment duration and the patient's overall health. Not every patient experiences the same side effects.
Common Side Effects of Chemotherapy
- 1. Nausea and Vomiting: Some chemotherapy medicines can cause nausea and vomiting. Doctors may prescribe antiemetic medicines to prevent or control these symptoms.
- 2. Hair Loss: Certain chemotherapy drugs affect hair follicles and may cause temporary hair loss. Hair usually starts growing back after treatment, although the timing varies.
- 3. Low Blood Counts: Chemotherapy can temporarily affect bone marrow function and reduce the production of normal blood cells:
• Neutropenia: Low neutrophil counts can increase the risk of infections.
• Anemia: Reduced red blood cells may cause weakness, fatigue and breathlessness.
• Thrombocytopenia: Low platelet counts can increase the risk of bruising and bleeding. - 4. Mouth Ulcers and Mucositis: Some patients develop mouth ulcers, soreness or difficulty swallowing. Oral hygiene, appropriate mouth care and prescribed medicines can help manage these symptoms.
- 5. Fatigue and Weakness: Tiredness is common during chemotherapy. Adequate rest, nutrition, hydration and appropriate physical activity may help patients manage fatigue.
- 6. Increased Risk of Infection: When white blood cell counts decrease, the body's ability to fight infections may be reduced. Fever during chemotherapy, particularly with neutropenia, requires urgent medical assessment.
How Can Chemotherapy Side Effects Be Managed?
Supportive care is an important part of cancer treatment. Depending on the patient's condition, doctors may recommend:
- Regular CBC and blood investigations.
- Antiemetic medicines to control nausea and vomiting.
- Blood or platelet transfusions when clinically indicated.
- Infection prevention measures and appropriate antimicrobial treatment.
- Nutritional support and adequate hydration.
- Oral care and medicines for mouth ulcers.
- Dose adjustments or treatment modifications when necessary.
Why Choose BMT Next for Chemotherapy in Gurgaon and Faridabad?
Choosing the right specialist team is important when undergoing chemotherapy, particularly for complex blood cancers and hematological conditions.
BMT Next at Marengo Asia Hospitals, Gurugram and Faridabad, provides specialized Hematology, Hemato-Oncology and Bone Marrow Transplant services. The team focuses on accurate diagnosis, individualized treatment planning and supportive care throughout the treatment journey.
What Makes BMT Next a Specialist Centre for Blood Cancer Care?
- Experienced Hematology Team: Led by Dr. Meet Kumar, Clinical Director & HOD – Hemato-Oncology & BMT, with expertise in complex blood cancers and hematological disorders.
- Adult and Pediatric Specialists: Dedicated expertise in adult and childhood leukemia, lymphoma and other blood disorders.
- Individualized Chemotherapy Planning: Treatment protocols selected according to cancer type, disease characteristics, molecular findings and patient fitness.
- Advanced Treatment Options: Evaluation for targeted therapy, immunotherapy, CAR-T cell therapy and bone marrow transplantation wherever clinically appropriate.
- Transplant Expertise: Marengo Asia Hospitals has performed 1,400+ bone marrow transplants.
- Continuous Monitoring: Assessment of treatment response, blood counts, side effects and supportive care requirements.
The objective is to provide evidence-based treatment planning and comprehensive care for patients with blood cancers and complex hematological conditions.
Frequently Asked Questions (FAQs)
Common questions regarding chemotherapy protocols, side effects, and blood cancer care in Gurgaon and Faridabad.
1. Who is the best doctor for chemotherapy in Gurgaon and Faridabad?
For patients with blood cancers such as leukemia, lymphoma and multiple myeloma, Dr. Meet Kumar, Clinical Director & HOD – Hemato-Oncology & BMT at BMT Next, Marengo Asia Hospitals, Gurugram and Faridabad, leads a specialist team providing evaluation and individualized treatment planning.
2. How many chemotherapy sessions are required?
The number of chemotherapy sessions depends on the type of cancer, treatment protocol, disease stage and response to treatment. Some patients require multiple cycles over several months, while others may need a different treatment schedule.
3. Is chemotherapy painful?
Chemotherapy administration through an IV line is generally not painful beyond the discomfort of inserting the cannula or accessing a port. However, some patients may experience side effects such as nausea, fatigue, mouth ulcers or body aches.
4. What are the common side effects of chemotherapy?
Common side effects include nausea, vomiting, hair loss, fatigue, mouth ulcers, low blood counts and increased infection risk. The side effects vary depending on the chemotherapy medicines used.
5. Is chemotherapy required before a bone marrow transplant?
In many transplant protocols, chemotherapy is given before stem cell infusion as part of a conditioning regimen. The type and intensity of treatment depend on the transplant approach, underlying disease and patient's overall health.
Consult a Specialist for Chemotherapy in Gurgaon and Faridabad
If you or a family member has been diagnosed with leukemia, lymphoma, multiple myeloma or another blood disorder, timely specialist evaluation is important. Consult Dr. Meet Kumar and the specialist Hemato-Oncology & BMT team at Marengo Asia Hospitals, Gurugram and Faridabad.